West Pharmaceutical Q3 Earnings Rise to $214 Million, Revenue Up 8.7%

West Pharmaceutical Services Inc. (WST) reported third-quarter earnings of $214.0 million, or $3.02 per share, up from $140.0 million, or $1.92 per share, a year earlier, the company said. Excluding items, adjusted earnings came in at $188.8 million, or $2.66 per share. Revenue for the period rose 8.7% to $874.5 million from $804.6 million last year. The company guided full-year EPS to a range of $9.38 to $9.48 and full-year revenue to $3.41 billion to $3.42 billion.